|Videos|November 21, 2019
Andre Machado, MD, PhD: The Evolution of Neuromodulation
Author(s)Andre Machado, MD, PhD
The Chairman of the Neurological Institute at Cleveland Clinic spoke to the history of neuromodulation and how it has evolved in clinical practice today.
Advertisement
“It is a very old idea, to treat the nervous system with electricity…but the modern use of neuromodulation with pacemaker-type devices was actually started here in Cleveland, some 50 years ago…the technology has evolved really well. Today, we do as much neuromodulation targeting the brain as we do targeting the spine and the nerves.”
Andre Machado, MD, PhD, Institute Chair, Neurological Institute, Cleveland Clinic, and colleagues are quite familiar with the use of neuromodulation techniques to treat movement disorders and other neurological illnesses. In fact, Machado told NeurologyLive that the process as we know it was originally enacted in Cleveland to treat chronic pain with spinal cord stimulation.
Now, neuromodulation procedures such as deep brain stimulation (DBS) have grown in popularity to become a more standard treatment for patients with Parkinson disease, among other conditions. Machado noted that increased use over time has paralleled the improvement, as the more it has been done, the safer it has become, and the more adept clinicians have become at utilizing it.
Machado spoke with NeurologyLive to offer insight into the evolution of neuromodulation treatment. He discussed its history, where he foresees its use going forward, as well as how it is being utilized in practice at Cleveland Clinic.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
3
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
4
2025 Women in Neurology Conference: Educating, Mentoring, and Networking
5